You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
  1. CORPORATE - 05-09-2018

    Kedrion joins Rhesus Solution Initiative (RSI) symposium in Lagos

    Nigeria to advocate for Rh Disease universal eradication

    read more 
  2. CORPORATE - 16-02-2018

    Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

    The prize is awarded to the companies that made the best use of the capital markets

    read more 
  3. CORPORATE - 10-01-2018

    Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme

    Goal is to improve access to replacement therapies for coagulation disorders in Europe

    read more 
For more information please contact: pressoffice@kedrion.com